Genetically Modified Mouse Models Used for Studying the Role of the AT2 Receptor in Cardiac Hypertrophy and Heart Failure

The actions of Angiotensin II have been implicated in many cardiovascular conditions. It is widely accepted that the cardiovascular effects of Angiotensin II are mediated by different subtypes of receptors: AT1 and AT2. These membrane-bound receptors share a part of their nucleic acid but seem to have different distribution and pathophysiological actions. AT1 mediates most of the Angiotensin II actions since it is ubiquitously expressed in the cardiovascular system of the normal adult. Moreover AT2 is highly expressed in the developing fetus but its expression in the cardiovascular system is low and declines after birth. However the expression of AT2 appears to be modulated by pathological states such as hypertension, myocardial infarction or any pathology associated to tissue remodeling or inflammation. The specific role of this receptor is still unclear and different studies involving in vivo and in vitro experiments have shown conflicting data. It is essential to clarify the role of the AT2 receptor in the different pathological states as it is a potential site for an effective therapeutic regimen that targets the Angiotensin II system. We will review the different genetically modified mouse models used to study the AT2 receptor and its association with cardiac hypertrophy and heart failure.

• Publication year

  2011

• Venue

  Journal of Biomedicine and Biotechnology

• Publication date

  2011-04-27

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1155/2011/141039PMID 21541238PMCID 3085212
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• I and J

  2012cited by this paper
• Pressure overload-induced hypertrophy in transgenic mice selectively overexpressing AT2 receptors in ventricular myocytes.

  2008cited by this paper
• Chronic ventricular myocyte-specific overexpression of angiotensin II type 2 receptor results in intrinsic myocyte contractile dysfunction.

  2005cited by this paper
• The Angiotensin II Type 2 Receptor Causes Constitutive Growth of Cardiomyocytes and Does Not Antagonize Angiotensin II Type 1 Receptor–Mediated Hypertrophy

  2005cited by this paper
• Γ and B

  2004influential reference
• Cardiac angiotensin AT2 receptor: what exactly does it do?

  2004cited by this paper
• Angiotensin AT2 receptors: cardiovascular hope or hype?

  2003cited by this paper
• Ventricular-specific expression of angiotensin II type 2 receptors causes dilated cardiomyopathy and heart failure in transgenic mice.

  2003cited by this paper
• Angiotensin II Type 2 Receptor Deficiency Exacerbates Heart Failure and Reduces Survival After Acute Myocardial Infarction in Mice

  2003cited by this paper
• A novel angiotensin II type 2 receptor signaling pathway: possible role in cardiac hypertrophy

  2003cited by this paper
• Angiotensin II Type 2 Receptor Overexpression Preserves Left Ventricular Function After Myocardial Infarction

  2002influential reference
• Renin-angiotensin system in human failing hearts: message from nonmyocyte cells to myocytes.

  2001cited by this paper
• Apoptosis Is Not Increased in Myocardium Overexpressing Type 2 Angiotensin II Receptor in Transgenic Mice

  2001cited by this paper
• AT(2), judgment day: which angiotensin receptor is the culprit in cardiac hypertrophy?

  2001cited by this paper
• Enhanced Angiotensin II Activity in Heart Failure: Reevaluation of the Counterregulatory Hypothesis of Receptor Subtypes

  2001cited by this paper
• Angiotensin II Type 2 Receptor Is Essential for Left Ventricular Hypertrophy and Cardiac Fibrosis in Chronic Angiotensin II–Induced Hypertension

  2001influential reference
• Inhibitory Effect of Angiotensin II Type 2 Receptor on Coronary Arterial Remodeling After Aortic Banding in Mice

  2000cited by this paper
• Evidence for angiotensin II type 2 receptor-mediated cardiac myocyte enlargement during in vivo pressure overload.

  2000cited by this paper
• Evidence for angiotensin II type 2 receptor-mediated cardiac myocyte enlargement during in vivo pressure overload

  2000influential reference
• Role of angiotensin AT1, and AT2 receptors in cardiac hypertrophy and disease.

  1999cited by this paper
• Recent progress in angiotensin II type 2 receptor research in the cardiovascular system.

  1999cited by this paper
• Segmental myocardial contractility versus perfusion in Kawasaki disease with coronary arterial aneurysm.

  1999cited by this paper
• Cardiac transgenic and gene-targeted mice as models of cardiac hypertrophy and failure: a problem of (new) riches.

  1998cited by this paper
• Immunolocalization of subtype 2 angiotensin II (AT2) receptor protein in rat heart.

  1998cited by this paper
• Angiotensin II type 2 receptor is upregulated in human heart with interstitial fibrosis, and cardiac fibroblasts are the major cell type for its expression.

  1998cited by this paper
• Cardiac-specific overexpression of angiotensin II AT2 receptor causes attenuated response to AT1 receptor-mediated pressor and chronotropic effects.

  1998influential reference
• Differential distribution of angiotensin AT2 receptors in the normal and failing human heart.

  1998cited by this paper
• Selective downregulation of the angiotensin II AT1-receptor subtype in failing human ventricular myocardium.

  1997cited by this paper
• Angiotensin type 2 receptors are reexpressed by cardiac fibroblasts from failing myopathic hamster hearts and inhibit cell growth and fibrillar collagen metabolism.

  1997cited by this paper
• Angiotensin II-mediated growth and antigrowth effects in cultured neonatal rat cardiac myocytes and fibroblasts.

  1997cited by this paper
• Differential Distribution of Angiotensin AT 2 Receptors in the Normal and Failing Human Heart 1

  1997cited by this paper
• Role of type 1 and type 2 angiotensin receptors in angiotensin II-induced cardiomyocyte hypertrophy.

  1996cited by this paper
• The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells.

  1995cited by this paper
• The angiotensin II type 2 (AT2) receptor antagonizes the growth effects of the AT1 receptor: gain-of-function study using gene transfer.

  1995cited by this paper
• Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor in mice.

  1995cited by this paper
• Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor gene in mice

  1995influential reference
• Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor

  1995cited by this paper
• Regulation, chamber localization, and subtype distribution of angiotensin II receptors in human hearts.

  1995cited by this paper
• Expression of AT2 receptors in the developing rat fetus.

  1991cited by this paper
• A and V

  1962cited by this paper
• and as an in

  year unknowncited by this paper
• AND T

  year unknowninfluential reference

• The Angiotensin AT2 Receptor: From a Binding Site to a Novel Therapeutic Target

  2022cites this paper
• Renin Activity in Heart Failure with Reduced Systolic Function—New Insights

  2019cites this paper
• Angiotensin-II Drives Human Satellite Cells Toward Hypertrophy and Myofibroblast Trans-Differentiation by Two Independent Pathways

  2019cites this paper
• Angiotensin II Signal Transduction: An Update on Mechanisms of Physiology and Pathophysiology.

  2018cites this paper
• Role of Kruppel-like Factor 8 (KLF8) in Cancer and Cardiomyopathy

  2016cites this paper
• Losartan reverses the down-expression of long noncoding RNA-NR024118 and Cdkn1c induced by angiotensin II in adult rat cardiac fibroblasts.

  2015cites this paper
• Mas/AT2 Cross Talk

  2015cites this paper
• Dyrk1A-ASF-CaMKIIδ Signaling Is Involved in Valsartan Inhibition of Cardiac Hypertrophy in Renovascular Hypertensive Rats

  2015cites this paper
• Opposite effects of angiotensins receptors type 2 and type 4 on streptozotocin induced diabetes vascular alterations in mice

  2014cites this paper
• Redox control of cardiovascular homeostasis by angiotensin II.

  2013cites this paper
• Reverse remodeling in heart failure—mechanisms and therapeutic opportunities

  2012cites this paper
• Metabolische Wirkungen des ersten nicht-peptidischen Angiotensin II Rezeptor Typ 2 Agonisten

  2012cites this paper
• Bioactive peptides: are there more antihypertensive mechanisms beyond ACE inhibition?

  2012cites this paper
• Pharmacogenomics Dictate Pharmacokinetics: Polymorphisms in Drug-Metabolizing Enzymes and Drug-Transporters

  2012cites this paper